Skip to main content

B 2.5 (Everolimus 2.5 mg)

Pill with imprint B 2.5 is White, Capsule-shape and has been identified as Everolimus 2.5 mg. It is supplied by Biocon Pharma Inc.

Everolimus is used in the treatment of neuroendocrine carcinoma; breast cancer; organ transplant, rejection prophylaxis; renal angiomyolipoma; pancreatic cancer and belongs to the drug classes mTOR inhibitors, selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy. Everolimus 2.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for B 2.5

Everolimus

Imprint
B 2.5
Strength
2.5 mg
Color
White
Shape
Capsule-shape
Availability
Prescription only
Drug Class
MTOR inhibitors, Selective immunosuppressants
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Biocon Pharma Inc.
National Drug Code (NDC)
70377-0010
Inactive Ingredients
butylated hydroxytoluene, hypromellose 2208 (3 mPa.s), crospovidone, lactose anhydrous, lactose monohydrate, magnesium stearate

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related images for "B 2.5"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.